InvestLog
DMAA Drugs Made In America Acquisition Corp. Ordinary Shares logo

DMAA Drugs Made In America Acquisition Corp. Ordinary Shares

Financial Services
$10.60+0.00%ClosedMarket Cap: $357.4M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

61.55

PEG

—

P/B

1.04

P/S

0.00

EV/EBITDA

-136.01

DCF Value

—

FCF Yield

-0.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

2.9%

ROA

2.8%

ROIC

-1.1%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$0.00$2.0M$—
Q4 null$0.00$213.0K$—
FY null$0.00$5.9M$—
Q3 null$0.00$2.2M$—

Trading Activity

Insider Trades

View All
Stockwell Lynndirector, 10 percent owner, officer: CEO and Exe. Chair of Board
BuyTue Feb 18
Drugs Made In America Acquisition LLC10 percent owner
BuyTue Feb 18
Stockwell Lynndirector, 10 percent owner, officer: CEO and Executive COB
SellTue Feb 04
Stockwell Lynndirector, 10 percent owner, officer: CEO and Executive COB
SellTue Feb 04
Drugs Made In America Acquisition LLC10 percent owner
SellTue Feb 04

Company Info

Sector

Financial Services

Industry

Shell Companies

Country

US

Exchange

—

Beta

-0.00

Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.

Peers

ALF logoALFLOKV logoLOKVMLAC logoMLACOYSE logoOYSERTAC logoRTACSIMA logoSIMATACH logoTACHTACO logoTACOTACOU logoTACOU